Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Rosen

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
BMJ (Clinical Research Ed.)|February 13, 2014
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisKelly Metcalfe, Shelley Gershman, Parviz Ghadirian, et al.
Journal of the National Cancer Institute|December 7, 2006
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, CanadaHarvey A Risch, John R McLaughlin, David E C Cole, et al.
JAMA Oncology|July 17, 2015
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriersJoanne Kotsopoulos, Beth Karlan, Jacek Gronwald, et al.
Gynecologic Oncology|March 19, 2017
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Jacob McGee, Vasily Giannakeas, Beth Karlan, et al.
Neoplasia (New York, N.Y.)|June 1, 2018
BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial CellsJulia Hollingsworth, Angela Lau, Alicia Tone, et al.
Nucleic Acids Research|October 6, 2017
An efficient method for generation of bi-allelic null mutant mouse embryonic stem cells and its application for investigating epigenetic modifiersCynthia L Fisher, Hendrik Marks, Lily Ting-Yin Cho, et al.
Advances in Radiation Oncology|December 11, 2020
Outcomes After Salvage Radiation Therapy for Recurrent Endometrial Cancer in Patients With No Prior Adjuvant Therapy: An Institutional ReviewJessica D Arden, Morgan F Gruner, Charles C Vu, et al.
Breast Cancer Research and Treatment|January 12, 2011
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Neoplasia (New York, N.Y.)|July 23, 2005
High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancerMarcus Bernardini, Chung-Hae Lee, Ben Beheshti, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|February 13, 2014
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisKelly Metcalfe, Shelley Gershman, Parviz Ghadirian, et al.
Journal of the National Cancer Institute|December 7, 2006
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, CanadaHarvey A Risch, John R McLaughlin, David E C Cole, et al.
JAMA Oncology|July 17, 2015
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriersJoanne Kotsopoulos, Beth Karlan, Jacek Gronwald, et al.
Gynecologic Oncology|March 19, 2017
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Jacob McGee, Vasily Giannakeas, Beth Karlan, et al.
Neoplasia (New York, N.Y.)|June 1, 2018
BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial CellsJulia Hollingsworth, Angela Lau, Alicia Tone, et al.
Nucleic Acids Research|October 6, 2017
An efficient method for generation of bi-allelic null mutant mouse embryonic stem cells and its application for investigating epigenetic modifiersCynthia L Fisher, Hendrik Marks, Lily Ting-Yin Cho, et al.
Advances in Radiation Oncology|December 11, 2020
Outcomes After Salvage Radiation Therapy for Recurrent Endometrial Cancer in Patients With No Prior Adjuvant Therapy: An Institutional ReviewJessica D Arden, Morgan F Gruner, Charles C Vu, et al.
Breast Cancer Research and Treatment|January 12, 2011
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Neoplasia (New York, N.Y.)|July 23, 2005
High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancerMarcus Bernardini, Chung-Hae Lee, Ben Beheshti, et al.
Pageof 15